Related Experiment Videos
Study on endoscopic esophageal mucosal resection with ligating device. I--Clinical study
Y Naritaka1, K Ogawa, T Shimakawa
1Department of Surgery, Tokyo Women's Medical University, Daini Hospital, 2-1-10 Nishiogu Arakawa-ku, Tokyo 116-8567, Japan. nari4121@ca.mbn.or.jp
Hepato-Gastroenterology
|August 9, 2001
Summary
Endoscopic esophageal mucosal resection with a ligating device (EEMRL) is effective for early esophageal cancer up to 2.5 cm. This minimally invasive technique shows promise for treating mucosal lesions without complications.
Area of Science:
- Gastroenterology
- Endoscopic Surgery
- Oncology
Background:
- Endoscopic esophageal mucosal resection with a ligating device (EEMRL) is gaining popularity for esophageal lesion treatment.
- Review of 13 clinical cases of EEMRL application.
Purpose of the Study:
- To evaluate the efficacy and safety of EEMRL for esophageal lesions.
- To determine the optimal size criteria for successful EEMRL treatment.
Main Methods:
- Performed EEMRL on 15 lesions in 13 patients since 1993.
- Included 12 squamous cell carcinomas (10 mucosal, 2 submucosal).
Main Results:
- Complete resection was achieved for lesions ≤2.5 cm in maximum diameter.
- EEMRL failed for 2 submucosal lesions >2.5 cm.
- No complications were reported during the procedure.
Conclusions:
- EEMRL is indicated for esophageal cancer ≤2.5 cm and confined to the mucosa.
- EEMRL is a technically simple, minimally invasive therapy for early esophageal cancer.